Baidu
map

Crit Care Med:美国综合医院卒中后姑息治疗中的种族差异!

2017-10-26 MedSci MedSci原创

中风后姑息治疗资源的使用在不同的种族/民族中存在差异,但是,患者或医院是否促使了这种差异目前尚不清楚。近期,一项发表在杂志Crit Care Med上的研究旨在确定在不同比例的少数患者医院之间,脑内出血和缺血性卒中后姑息治疗是否有所不同。此项研究是基于人群的横断面研究。受试对象来源于2007年至2011年间全国住院患者。最终,共有46,735例脑内出血和331,521例缺血性卒中患者入选。此项研究

中风后姑息治疗资源的使用在不同的种族/民族中存在差异,但是,患者或医院是否促使了这种差异目前尚不清楚。


近期,一项发表在杂志Crit Care Med上的研究旨在确定在不同比例的少数患者医院之间,脑内出血和缺血性卒中后姑息治疗是否有所不同。

此项研究是基于人群的横断面研究。受试对象来源于2007年至2011年间全国住院患者。最终,共有46,735例脑内出血和331,521例缺血性卒中患者入选。此项研究的干预为姑息治疗的使用。

2007年至2011年间,从全国住院病人样本中确定了脑内出血和缺血性卒中入院的患者。根据少数民族卒中患者的百分比(<25%的少数民族[“白色医院”],25-50%的少数民族医院“混合医院”],或> 50%的少数民族[”少数民族医院“])。使用Logistic回归评估不同医院层次之间和种族/民族与姑息治疗的关系。

在少数民族医院,接受姑息治疗的中风患者与“白色医院”治疗相比几率更低,无论个别患者种族/种族(调整后的脑出血优势比为0.65;95%CI为0.50-0.84;缺血性脑卒中优势比为0.62;95%CI为0.50-0.77)。

在医院层面,与“白色医院”相比,少数民族接受姑息治疗的可能性较低,但与“白色医院”相比,白人和少数脑内出血患者的姑息治疗的可能性较低(白色医院的比优势比为0.66;95%CI为0.50-0.87;少数民族患者的优势比为0.64;95%CI,0.46-0.88)。此外,在缺血性卒中中也观察到类似的结果。

此项研究结果表明:对于白人和少数民族中风患者来说,接受姑息治疗的机会少于“白色医院”,这表明系统水平因素是解释卒中后姑息治疗使用中种族差距的主要因素。

原始出处:
Faigle R, Ziai WC, et al. Racial Differences in Palliative Care Use After Stroke in Majority-White, Minority-Serving, and Racially Integrated U.S. Hospitals. Crit Care Med. 2017 Oct 14. doi: 10.1097/CCM.0000000000002762.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1695548, encodeId=3b641695548a5, content=<a href='/topic/show?id=3c9ce911681' target=_blank style='color:#2F92EE;'>#综合医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79116, encryptionId=3c9ce911681, topicName=综合医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a1429829192, createdName=amyloid, createdTime=Thu Apr 26 12:04:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671319, encodeId=f76c16e1319d2, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7426824786, createdName=waiwai3039, createdTime=Sat May 05 14:04:00 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353571, encodeId=f49213535e145, content=<a href='/topic/show?id=29e1e4781f1' target=_blank style='color:#2F92EE;'>#种族差异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74781, encryptionId=29e1e4781f1, topicName=种族差异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Oct 28 08:04:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608163, encodeId=d9441608163e4, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Oct 28 08:04:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626649, encodeId=930c1626649f9, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Sat Oct 28 08:04:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256187, encodeId=f87725618efc, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Oct 26 19:50:38 CST 2017, time=2017-10-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1695548, encodeId=3b641695548a5, content=<a href='/topic/show?id=3c9ce911681' target=_blank style='color:#2F92EE;'>#综合医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79116, encryptionId=3c9ce911681, topicName=综合医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a1429829192, createdName=amyloid, createdTime=Thu Apr 26 12:04:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671319, encodeId=f76c16e1319d2, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7426824786, createdName=waiwai3039, createdTime=Sat May 05 14:04:00 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353571, encodeId=f49213535e145, content=<a href='/topic/show?id=29e1e4781f1' target=_blank style='color:#2F92EE;'>#种族差异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74781, encryptionId=29e1e4781f1, topicName=种族差异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Oct 28 08:04:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608163, encodeId=d9441608163e4, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Oct 28 08:04:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626649, encodeId=930c1626649f9, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Sat Oct 28 08:04:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256187, encodeId=f87725618efc, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Oct 26 19:50:38 CST 2017, time=2017-10-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1695548, encodeId=3b641695548a5, content=<a href='/topic/show?id=3c9ce911681' target=_blank style='color:#2F92EE;'>#综合医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79116, encryptionId=3c9ce911681, topicName=综合医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a1429829192, createdName=amyloid, createdTime=Thu Apr 26 12:04:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671319, encodeId=f76c16e1319d2, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7426824786, createdName=waiwai3039, createdTime=Sat May 05 14:04:00 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353571, encodeId=f49213535e145, content=<a href='/topic/show?id=29e1e4781f1' target=_blank style='color:#2F92EE;'>#种族差异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74781, encryptionId=29e1e4781f1, topicName=种族差异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Oct 28 08:04:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608163, encodeId=d9441608163e4, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Oct 28 08:04:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626649, encodeId=930c1626649f9, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Sat Oct 28 08:04:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256187, encodeId=f87725618efc, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Oct 26 19:50:38 CST 2017, time=2017-10-26, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1695548, encodeId=3b641695548a5, content=<a href='/topic/show?id=3c9ce911681' target=_blank style='color:#2F92EE;'>#综合医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79116, encryptionId=3c9ce911681, topicName=综合医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a1429829192, createdName=amyloid, createdTime=Thu Apr 26 12:04:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671319, encodeId=f76c16e1319d2, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7426824786, createdName=waiwai3039, createdTime=Sat May 05 14:04:00 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353571, encodeId=f49213535e145, content=<a href='/topic/show?id=29e1e4781f1' target=_blank style='color:#2F92EE;'>#种族差异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74781, encryptionId=29e1e4781f1, topicName=种族差异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Oct 28 08:04:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608163, encodeId=d9441608163e4, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Oct 28 08:04:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626649, encodeId=930c1626649f9, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Sat Oct 28 08:04:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256187, encodeId=f87725618efc, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Oct 26 19:50:38 CST 2017, time=2017-10-26, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1695548, encodeId=3b641695548a5, content=<a href='/topic/show?id=3c9ce911681' target=_blank style='color:#2F92EE;'>#综合医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79116, encryptionId=3c9ce911681, topicName=综合医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a1429829192, createdName=amyloid, createdTime=Thu Apr 26 12:04:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671319, encodeId=f76c16e1319d2, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7426824786, createdName=waiwai3039, createdTime=Sat May 05 14:04:00 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353571, encodeId=f49213535e145, content=<a href='/topic/show?id=29e1e4781f1' target=_blank style='color:#2F92EE;'>#种族差异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74781, encryptionId=29e1e4781f1, topicName=种族差异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Oct 28 08:04:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608163, encodeId=d9441608163e4, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Oct 28 08:04:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626649, encodeId=930c1626649f9, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Sat Oct 28 08:04:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256187, encodeId=f87725618efc, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Oct 26 19:50:38 CST 2017, time=2017-10-26, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1695548, encodeId=3b641695548a5, content=<a href='/topic/show?id=3c9ce911681' target=_blank style='color:#2F92EE;'>#综合医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79116, encryptionId=3c9ce911681, topicName=综合医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a1429829192, createdName=amyloid, createdTime=Thu Apr 26 12:04:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671319, encodeId=f76c16e1319d2, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7426824786, createdName=waiwai3039, createdTime=Sat May 05 14:04:00 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353571, encodeId=f49213535e145, content=<a href='/topic/show?id=29e1e4781f1' target=_blank style='color:#2F92EE;'>#种族差异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74781, encryptionId=29e1e4781f1, topicName=种族差异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Oct 28 08:04:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608163, encodeId=d9441608163e4, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Oct 28 08:04:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626649, encodeId=930c1626649f9, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Sat Oct 28 08:04:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256187, encodeId=f87725618efc, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Oct 26 19:50:38 CST 2017, time=2017-10-26, status=1, ipAttribution=)]
    2017-10-26 131****1460

    学习了受益匪浅

    0

相关资讯

表现为卒中 真凶竟然是……

中年女性,因“头晕、言语不清14日”于2009年5月1日入院。患者14日前突然出现头晕,自觉言语不清,恶心,未呕吐,饮水偶有呛咳,全身乏力,肢体活动基本同前,在当地卫生室应用丹参、苦碟子注射液静脉点滴治疗14日,病情无缓解,以“脑梗死”收入院。既往史:15年前出现不明原因低热、面部盘状红斑、双手指关节疼痛肿胀,脱发,化验示抗核抗体(ANA)(+),抗双链DNA抗体(ds-DNA)(+),确诊系统性

Stroke:卒中康复后功能结局的预测模型!

卒中康复后的预后可以帮助临床医师进行康复护理的相关决策和规划。近期,一项发表在杂志Stroke上的研究开发和验证了一种预测工具,用于估计在卒中康复后实现身体功能改善的可能性(模型1)以及仅仅需要监督的一定程度的独立(模型2)。此项研究的模型来自717例入院的中风康复患者。研究者们使用多变量逻辑回归分析来构建每个模型。然后,每个模型在875例患者中进行前瞻性验证。此项研究结果显示:模型1包括了年龄,

黑龙江发布卒中急救地图 28家医院形成“黄金急救圈”

黑龙江省卫计委21日发布了黑龙江省卒中急救地图,确定了首批28家急性脑卒中医疗救治定点医院,形成覆盖上千万人口的快速救治网络,使卒中患者在最短时间内得到有效的救治。

二手烟增加卒中风险

据一项最新的研究发现,暴露于二手烟(SHS)之下增加约30%的卒中风险,且与人口学特征、社会经济因素、吸烟史、弗雷明汉卒中危险因素、c-反应蛋白(crp)浓度独立相关。该基于群体的纵向研究纳入了 21,743位受试者进行总体卒中分析,调查大于45岁的心血管疾病人群死亡率。报告称在过去1年中,约四分之一(23%)的受试者SHS暴露,77% 的人非SHS暴露。与非暴露者相比,那些报告为暴露者明显更加年

J Rheumatol:系统性红斑狼疮卒中后的死亡率和功能障碍

与非SLE患者相比,SLE患者第一个月后缺血性卒中的死亡率升高,3个月时的功能更差。

房颤患者易卒中!Lip博士来帮忙

调查数据显示,房颤抗凝治疗遵循指南的依从性较差。与欧美相比,亚太地区在心房颤动(房颤)领域的研究较为落后,在流行病学、抗栓药物疗效的评价及其对预后影响等方面缺乏数据。 预防用药一项间接比较三种口服抗凝药物达比加群、利伐沙班和阿哌沙班的研究显示,在房颤卒中预防中三种药物的相对疗效和安全性有一定的差异。然而,研究人员发现整体相似性大于差异,并停止讨论药物差异对于临床医生选择药物的引导作用,他

Baidu
map
Baidu
map
Baidu
map